![](/img/cover-not-exists.png)
Recombinant human erythropoietin alters subcutaneous resistance artery endothelial function through a mechanism involving oxidative stress and endothelin-1 in patients with stage 4 chronic kidney disease
M. Briet, T. Barhoumi, M. Davidman, D. Bercovitch, G. Frisch, S.J. Nessim, M.L. Lipman, E.L. SchiffrinVolume:
5
Year:
2011
Language:
english
DOI:
10.1016/j.artres.2011.10.024
File:
PDF, 67 KB
english, 2011